Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 98

Results For "Post"

1357 News Found

COVID-19 infected 9-year-child successfully gets a heart transplant at Masinda Heart Institute
Healthcare | June 16, 2022

COVID-19 infected 9-year-child successfully gets a heart transplant at Masinda Heart Institute

Many kids who have heart transplants live a normal, healthy life once they recover from surgery.


Sir H N Reliance Foundation Hospital performs India’s first Sapien3 Tricuspid implant
Healthcare | June 16, 2022

Sir H N Reliance Foundation Hospital performs India’s first Sapien3 Tricuspid implant

63-year old woman gets rare Transcatheter Tricuspid Valve Replacement (TTVR)


QIAGEN selects TCS for cloud transformation strategy
Digitisation | June 16, 2022

QIAGEN selects TCS for cloud transformation strategy

QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth


InfuSystem and Ventis ink sales agreement for pain management
News | June 15, 2022

InfuSystem and Ventis ink sales agreement for pain management

The company will offer Ventis Pharma’s patented local anesthetic compound, Endura-KitTM for post-operative surgical and chronic pain management


Philips announces positive research results from its TOBA II BTK clinical trial
Clinical Trials | June 14, 2022

Philips announces positive research results from its TOBA II BTK clinical trial

First and only FDA-approved device of its kind demonstrates consistently high rates of target limb salvage and freedom from clinically-driven target lesion revascularization


Sanofi-GSK next-gen COVID-19 booster delivers strong immune response against main variants
News | June 14, 2022

Sanofi-GSK next-gen COVID-19 booster delivers strong immune response against main variants

Next-generation booster vaccine candidate demonstrates potential to protect against COVID-19 variants of concern, including Omicron BA.1 and BA.2, with a favorable safety and tolerability profile


Merck and Ridgeback announce new data for investigational molnupiravir
News | June 08, 2022

Merck and Ridgeback announce new data for investigational molnupiravir

Based on a post hoc analysis, fewer required respiratory interventions


ANG Lifesciences India Q4 FY 22 net profit soars to Rs. 5.28 Cr
News | June 08, 2022

ANG Lifesciences India Q4 FY 22 net profit soars to Rs. 5.28 Cr

The company has posted net profit of Rs.39.71 crores for the Financial Year ended March 31, 2022.


IOL Chemicals and Pharmaceuticals Q4 FY2022 PAT drops to Rs. 27.75 Cr
News | June 08, 2022

IOL Chemicals and Pharmaceuticals Q4 FY2022 PAT drops to Rs. 27.75 Cr

The company has posted net profit of Rs.165.66 crores for the Financial Year ended March 31, 2022


NewAmsterdam Pharma shares new data from Phase 2b ROSE Study
News | June 07, 2022

NewAmsterdam Pharma shares new data from Phase 2b ROSE Study

82.5% of patients treated at 10mg dose of obicetrapib achieved LDL-c target of <70 mg/dL, compared to 20% of patients treated with placebo